Business Risk Profile: Pharmaceuticals

Companies in the innovation-driven pharmaceutical industry are no strangers to risk. Operational risk is an inherent aspect of pharmaceutical research and development, with 4.9 percent of new drugs making it from first toxicity dose to final market approval. Pharmaceutical companies also face financial and strategic risks when bringing new drugs to market, as well as compliance risks from navigating the ever-changing regulatory landscape.

Default Author Image
March 21, 2018